Transmission of C9orf72 hexanucleotide repeat expansions in sporadic amyotrophic lateral sclerosis: an Australian trio study

Neuroreport
Roger PamphlettBing Yu

Abstract

Abnormally expanded C9orf72 hexanucleotide repeats are found in up to 7% of patients with sporadic amyotrophic lateral sclerosis (SALS). It is not known whether the sporadic nature of the disease represents incomplete penetrance of the phenotype or expansion of the repeat in the SALS patient. The sizes of C9orf72 hexanucleotide repeats were measured in blood DNA of 43 SALS patients and their parents who had no symptoms of ALS. Two SALS patients (4.7%) had abnormally expanded (>30 repeats) C9orf72 repeats. Both of their fathers (one with dementia) also had abnormally expanded repeats. Nine SALS patients had intermediate-normal repeat sizes (7-30 repeats); in each of these, one parent had a similar repeat size. In the remaining 32 SALS patients, the repeat sizes were low-normal (<7 repeats). There was no evidence of repeat instability leading to abnormal numbers of repeats in any SALS patient in this trio cohort. Our results suggest that a simple monogenic mechanism is not likely to be the cause of C9orf72 repeat-related SALS.

References

Feb 8, 2011·Lancet·Matthew C KiernanMargaret C Zoing
Jan 6, 2012·The New England Journal of Medicine·Elisa MajounieBryan J Traynor
Mar 1, 2012·Brain : a Journal of Neurology·Johnathan Cooper-KnockPamela J Shaw

❮ Previous
Next ❯

Citations

Aug 15, 2012·Acta Neuropathologica·Anne SiebenMarc Cruts
Jun 12, 2013·Trends in Neurosciences·Marc CrutsChristine Van Broeckhoven
Aug 13, 2013·Molecular Neurobiology·Ying LiuLan Tan
Feb 12, 2014·Acta Neuropathologica·Ione O C Woollacott, Simon Mead
Oct 5, 2013·Journal of the Neurological Sciences·Ying LiuLan Tan
Nov 1, 2012·Human Mutation·Julie van der ZeeUNKNOWN European Early-Onset Dementia Consortium
Apr 5, 2013·Bipolar Disorders·Miriam H MeislerMelvin G McInnis
Jan 29, 2017·Cold Spring Harbor Perspectives in Medicine·Ilse GijselinckChristine Van Broeckhoven
Oct 29, 2018·Acta Neuropathologica·Sarat C VatsavayaiWilliam W Seeley
May 20, 2017·Scientific Reports·Natalie A MurphyBryan J Traynor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.